CTKB
Cytek Biosciences Inc
5.30$
-0.4%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +212.6% | +110.6% | +12.1% | -4.8% | +1.0% | -7.6% | |
| – | +207.9% | +106.9% | +5.2% | -13.6% | +1.1% | -1.1% | |
| – | +448.5% | +120.7% | -18.7% | -43.6% | -41.0% | -8.0% | |
| – | +448.5% | +120.7% | -6.4% | -23.1% | +5.9% | -5.9% | |
| – | +2.0% | +63.7% | +71.7% | +10.3% | +8.0% | +19.0% | |
| – | +24.9% | +39.8% | +49.7% | +26.4% | -27.9% | +10.3% | |
| – | +105.6% | +173.4% | +133.8% | – | – | – | |
| – | +0.0% | +2,031.1% | +0.0% | +59.5% | +3.0% | +0.2% | |
| – | +4.2% | +1,629.6% | -8.6% | +433.0% | -12.8% | -16.4% | |
| – | +110.6% | -75.5% | +62.2% | +7.9% | +2.3% | +15.5% | |
| – | +26.1% | +25.0% | +47.8% | +14.7% | +20.3% | +15.0% | |
| – | -61.6% | +450.2% | -77.0% | -14.3% | +179.6% | +9.1% | |
| – | +25.7% | +3.1% | +58.4% | -36.9% | +82.4% | +15.9% | |
| – | – | – | – | -27.4% | -36.3% | -50.0% | |
| – | – | – | +5.0% | -7.6% | +0.7% | -13.6% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +0.6% | +3.6% | -2.4% | -3.5% | -2.2% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.